TGM2 and cancer: The protein cross-linking enzyme transglutaminase-2 (TG2) has been linked to several cancer types and has been implicated in a variety of processes associated with cancer cell behaviour including chemoresistance, apoptosis, invasion, migration, stemness and involvement in epithelial-mesenchymal transition [3,4,5,6,7,8,9].